Cargando…
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
OBJECTIVE: The management of cardiotoxicity concerning the use of oral antineoplastic agents (OAAs) is a challenge for healthcare professionals. Our objective was to create a comprehensive medication management guide with dose adjustment recommendations on OAAs concerning cardiotoxic and lipid metab...
Autores principales: | Ramos-Ruperez, Elena, Escudero-Vilaplana, Vicente, Ruiz-Briones, Paula, Collado-Borrell, Roberto, Villanueva-Bueno, Cristina, Revuelta-Herrero, José Luis, González-Haba, Eva, Garcia-Gonzalez, Xandra, Ibañez-Garcia, Sara, Perez-Ramirez, Sara, Zatarain-Nicolás, Eduardo, Herranz, Ana, Sanjurjo, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485602/ https://www.ncbi.nlm.nih.gov/pubmed/37692846 http://dx.doi.org/10.3389/fonc.2023.1220305 |
Ejemplares similares
-
A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital
por: Villanueva-Bueno, Cristina, et al.
Publicado: (2022) -
Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis
por: Collado-Borrell, Roberto, et al.
Publicado: (2020) -
Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective
por: Marzal-Alfaro, María Belen, et al.
Publicado: (2021) -
A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application
por: García-Sánchez, Sebastián, et al.
Publicado: (2022) -
Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey
por: Collado-Borrell, Roberto, et al.
Publicado: (2018)